Search

everythinglearnresearchcommunity

for

Search:↓

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Increased energy use in Pik3r1-related insulin resistance isn't due to Ucp1 thermogenesis.

Mixing platelet-rich plasma with triamcinolone acetonide can potentially improve hair regrowth in alopecia areata patients.

Dapagliflozin improved blood sugar control in a man with Werner syndrome without side effects.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Retinoids can help treat skin pigmentation disorders by affecting melanin production.

Ro 10-9359 is an effective treatment for severe psoriasis but can cause side effects.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

The rash resolved after stopping ponatinib.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Diane is effective for treating acne, seborrhoea, androgenic alopecia, and mild hirsutism in women.

Increasing TSPO in the brain reduces anxiety and depression.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

Trazodone might help reverse post finasteride syndrome.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.